| Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review S Elyasi, H Khalili, S Dashti-Khavidaki, A Mohammadpour European journal of clinical pharmacology 68, 1243-1255, 2012 | 497 | 2012 |
| Potential renoprotective effects of silymarin against nephrotoxic drugs: a review of literature F Shahbazi, S Dashti-Khavidaki, H Khalili, M Lessan-Pezeshki Journal of Pharmacy & Pharmaceutical Sciences 15 (1), 112-123, 2012 | 137 | 2012 |
| Role of clinical pharmacists’ interventions in detection and prevention of medication errors in a medical ward H Khalili, S Farsaei, H Rezaee, S Dashti-Khavidaki International journal of clinical pharmacy 33, 281-284, 2011 | 122 | 2011 |
| Considerations for statin therapy in patients with COVID‐19 S Dashti‐Khavidaki, H Khalili Pharmacotherapy 40 (5), 484, 2020 | 119 | 2020 |
| Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention A Jafari, H Khalili, S Dashti-Khavidaki European journal of clinical pharmacology 70, 1029-1040, 2014 | 118 | 2014 |
| Improvement of knowledge, attitude and perception of healthcare workers about ADR, a pre-and post-clinical pharmacists' interventional study H Khalili, N Mohebbi, N Hendoiee, AA Keshtkar, S Dashti-Khavidaki BMJ open 2 (1), e000367, 2012 | 112 | 2012 |
| Association between depression and inflammatory/anti‐inflammatory cytokines in chronic kidney disease and end‐stage renal disease patients: A review of literature M Taraz, S Taraz, S Dashti‐Khavidaki Hemodialysis International 19 (1), 11-22, 2015 | 100 | 2015 |
| Comparing the effects of 8-week treatment with fluoxetine and imipramine on fasting blood glucose of patients with major depressive disorder P Ghaeli, E Shahsavand, M Mesbahi, MZ Kamkar, M Sadeghi, ... Journal of clinical psychopharmacology 24 (4), 386-388, 2004 | 95 | 2004 |
| Sertraline decreases serum level of interleukin-6 (IL-6) in hemodialysis patients with depression: results of a randomized double-blind, placebo-controlled clinical trial M Taraz, MR Khatami, S Dashti-Khavidaki, S Akhonzadeh, AA Noorbala, ... International immunopharmacology 17 (3), 917-923, 2013 | 81 | 2013 |
| Impact of neuraminidase inhibitors on influenza A (H1N1) pdm09‐related pneumonia: an individual participant data meta‐analysis SG Muthuri, S Venkatesan, PR Myles, J Leonardi‐Bee, WS Lim, ... Influenza and other respiratory viruses 10 (3), 192-204, 2016 | 79 | 2016 |
| Tribulus terrestris-induced severe nephrotoxicity in a young healthy male AH Talasaz, MR Abbasi, S Abkhiz, S Dashti-Khavidaki Nephrology Dialysis Transplantation 25 (11), 3792-3793, 2010 | 79 | 2010 |
| 7 Adverse Reactions of Prophylactic Intravenous Immunoglobulin; A 13-Year Experience With 3004 Infusions in Iranian Patients With Primary Immunodeficiency Diseases S Dashti-Khavidaki, A Aghamohammadi, F Farshadi, M Movahedi, ... Journal of investigational allergology & clinical immunology 19 (2), 139, 2009 | 77 | 2009 |
| Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost H Khalili, I Karimzadeh, P Mirzabeigi, S Dashti-Khavidaki European journal of internal medicine 24 (3), 227-233, 2013 | 76 | 2013 |
| Nutritional status and serum zinc and selenium levels in Iranian HIV infected individuals H Khalili, A Soudbakhsh, M Hajiabdolbaghi, S Dashti-Khavidaki, ... BMC Infectious Diseases 8, 1-7, 2008 | 73 | 2008 |
| Effect of silymarin administration on cisplatin nephrotoxicity: report from a pilot, randomized, double‐blinded, placebo‐controlled clinical trial F Shahbazi, S Sadighi, S Dashti‐Khavidaki, F Shahi, M Mirzania, ... Phytotherapy Research 29 (7), 1046-1053, 2015 | 69 | 2015 |
| Anti-tuberculosis drugs related hepatotoxicity; incidence, risk factors, pattern of changes in liver enzymes and outcome H Khalili, KS DASHTI, M RASOULINEZHAD, L REZAEI, M Etminani DARU JOURNAL OF PHARMACEUTICAL SCIENCE 17 (3), 163-167, 2009 | 68 | 2009 |
| The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial A Gharekhani, MR Khatami, S Dashti-Khavidaki, E Razeghi, AA Noorbala, ... European journal of clinical pharmacology 70, 655-665, 2014 | 67 | 2014 |
| Descriptive analysis of a clinical pharmacy intervention to improve the appropriate use of stress ulcer prophylaxis in a hospital infectious disease ward H Khalili, S Dashti-Khavidaki, AHH Talasaz, H Tabeefar, N Hendoiee Journal of Managed Care Pharmacy 16 (2), 114-121, 2010 | 64 | 2010 |
| Effects of oral supplementation with omega-3 fatty acids on nutritional state and inflammatory markers in maintenance hemodialysis patients A Gharekhani, MR Khatami, S Dashti-Khavidaki, E Razeghi, A Abdollahi, ... Journal of Renal Nutrition 24 (3), 177-185, 2014 | 63 | 2014 |
| Serum zinc concentrations in patients on maintenance hemodialysis and its relationship with anemia, parathyroid hormone concentrations and pruritus severity S Dashti-Khavidaki, H Khalili, SM Vahedi, M Lessan-Pezeshki Saudi Journal of Kidney Diseases and Transplantation 21 (4), 641-645, 2010 | 62 | 2010 |
